Do alpha-tocopherol distribution in lipoproteins and anti-inflammatory effects differ between CHD-patients and healthy subjects?
Our data demonstrate that CHD-patients require lower dosages of alpha-tocopherol supplementation than healthy subjects to exert biological effects on plasma lipoproteins and acute phase response.
Contrary to our expectations, EPA supplementation lowered postprandial beta-OHB response and, in the elderly subjects, the concentration of postprandial beta-OHB was not lowered after intake of the EPA supplement.